Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cefixime
2. Cefixime Anhydrous
3. Cefixime Trihydrate
4. Fk 027
5. Fk-027
6. Fk027
7. Fr 17027
8. Fr-17027
9. Fr17027
1. Cefixime
2. 97164-56-2
3. 79350-37-1
4. Cefixime(e)-form
5. (e)-cefixime
6. Cefixime Anhydrous, (e)-
7. U7rwt9j78o
8. Cfix
9. (6r,7r)-7-(((2e)-2-(2-amino-4-thiazolyl)-2-((carboxymethoxy)imino)acetyl)amino)-3-ethenyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
10. (6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
11. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2e)-2-(2-amino-4-thiazolyl)-2-((carboxymethoxy)imino)acetyl)amino)-3-ethenyl-8-oxo-, (6r,7r)-
12. Cefixime Impurity D
13. Unii-u7rwt9j78o
14. (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
15. Cefiximetrihydrate
16. Prestwick2_000462
17. Epitope Id:116227
18. Schembl24946
19. Schembl49534
20. Chembl427069
21. Bdbm88962
22. Chebi:93248
23. Gtpl10898
24. Cid_56642849
25. Hms1569m06
26. (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-((carboxymethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
27. Zinc4468778
28. Ncgc00185001-01
29. (e)-cefixime (cefixime Ep Impurity D)
30. Q163901
31. J-005196
32. J-501698
33. Brd-k04993501-001-01-9
34. [6r-[6alpha,7beta(e)]]-7-[[(2-amino-4-thiazolyl)[(car
35. (6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
36. (6r,7r)-7-[[(2e)-2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
37. (6r,7r)-7-[[(2e)-2-(2-aminothiazol-4-yl)-2-(carboxymethyloximino)acetyl]amino]-8-keto-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
38. (6r,7r)-7-[[(2e)-2-(2-azanyl-1,3-thiazol-4-yl)-2-(2-hydroxy-2-oxoethyloxyimino)ethanoyl]amino]-3-ethenyl-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrate
39. (6r,7r)-7-[[(2z)-2-(2-amino-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene -2-carboxylic Acid
40. (6r,7r,e)-7-(2-(2-aminothiazol-4-yl)-2-(carboxymethoxyimino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
| Molecular Weight | 453.5 g/mol |
|---|---|
| Molecular Formula | C16H15N5O7S2 |
| XLogP3 | -0.7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | 453.04129018 g/mol |
| Monoisotopic Mass | 453.04129018 g/mol |
| Topological Polar Surface Area | 238 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 861 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DD - Third-generation cephalosporins
J01DD08 - Cefixime
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
Certificate Number : R1-CEP 1999-158 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2007-04-04
Type : Chemical
Substance Number : 1188
Certificate Number : R1-CEP 2001-073 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2006-07-13
Type : TSE
Substance Number : 1188
Certificate Number : R1-CEP 2003-014 - Rev 02
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2014-06-02
Type : Chemical
Substance Number : 1188
Certificate Number : R0-CEP 2014-217 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2016-12-02
Type : Chemical
Substance Number : 1188
Certificate Number : R0-CEP 2004-123 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2007-08-01
Type : Chemical
Substance Number : 1188
Certificate Number : R1-CEP 2011-239 - Rev 00
Status : Suspended by EDQM GMP non-compliance
Issue Date : 2019-03-08
Type : Chemical
Substance Number : 1188
Certificate Number : R1-CEP 2009-347 - Rev 02
Status : Valid
Issue Date : 2018-10-31
Type : Chemical
Substance Number : 1188
Certificate Number : R0-CEP 2010-192 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2014-01-08
Type : Chemical
Substance Number : 1188
Certificate Number : R1-CEP 2001-449 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2008-05-14
Type : Chemical
Substance Number : 1188
Certificate Number : R0-CEP 2007-314 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2010-01-21
Type : Chemical
Substance Number : 1188
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - FOR SUSPENSION;ORAL - 500MG/5ML
USFDA APPLICATION NUMBER - 202091
DOSAGE - CAPSULE;ORAL - 400MG
USFDA APPLICATION NUMBER - 203195
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Thickeners and Stabilizers
Direct Compression
Taste Masking
Granulation
Controlled & Modified Release
Chewable & Orodispersible Aids
Topical
Disintegrants & Superdisintegrants
Lubricants & Glidants
Co-Processed Excipients
Film Formers & Plasticizers
Empty Capsules
Solubilizers
Rheology Modifiers
Parenteral
Coloring Agents
Emulsifying Agents
API Stability Enhancers
Vegetarian Capsules
Surfactant & Foaming Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
61
PharmaCompass offers a list of Cefixime API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cefixime manufacturer or Cefixime supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefixime manufacturer or Cefixime supplier.
PharmaCompass also assists you with knowing the Cefixime API Price utilized in the formulation of products. Cefixime API Price is not always fixed or binding as the Cefixime Price is obtained through a variety of data sources. The Cefixime Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AC1O426C manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AC1O426C, including repackagers and relabelers. The FDA regulates AC1O426C manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AC1O426C API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of AC1O426C manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A AC1O426C supplier is an individual or a company that provides AC1O426C active pharmaceutical ingredient (API) or AC1O426C finished formulations upon request. The AC1O426C suppliers may include AC1O426C API manufacturers, exporters, distributors and traders.
click here to find a list of AC1O426C suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A AC1O426C DMF (Drug Master File) is a document detailing the whole manufacturing process of AC1O426C active pharmaceutical ingredient (API) in detail. Different forms of AC1O426C DMFs exist exist since differing nations have different regulations, such as AC1O426C USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A AC1O426C DMF submitted to regulatory agencies in the US is known as a USDMF. AC1O426C USDMF includes data on AC1O426C's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The AC1O426C USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of AC1O426C suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The AC1O426C Drug Master File in Japan (AC1O426C JDMF) empowers AC1O426C API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the AC1O426C JDMF during the approval evaluation for pharmaceutical products. At the time of AC1O426C JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of AC1O426C suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a AC1O426C Drug Master File in Korea (AC1O426C KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of AC1O426C. The MFDS reviews the AC1O426C KDMF as part of the drug registration process and uses the information provided in the AC1O426C KDMF to evaluate the safety and efficacy of the drug.
After submitting a AC1O426C KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their AC1O426C API can apply through the Korea Drug Master File (KDMF).
click here to find a list of AC1O426C suppliers with KDMF on PharmaCompass.
A AC1O426C CEP of the European Pharmacopoeia monograph is often referred to as a AC1O426C Certificate of Suitability (COS). The purpose of a AC1O426C CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of AC1O426C EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of AC1O426C to their clients by showing that a AC1O426C CEP has been issued for it. The manufacturer submits a AC1O426C CEP (COS) as part of the market authorization procedure, and it takes on the role of a AC1O426C CEP holder for the record. Additionally, the data presented in the AC1O426C CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the AC1O426C DMF.
A AC1O426C CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. AC1O426C CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of AC1O426C suppliers with CEP (COS) on PharmaCompass.
A AC1O426C written confirmation (AC1O426C WC) is an official document issued by a regulatory agency to a AC1O426C manufacturer, verifying that the manufacturing facility of a AC1O426C active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting AC1O426C APIs or AC1O426C finished pharmaceutical products to another nation, regulatory agencies frequently require a AC1O426C WC (written confirmation) as part of the regulatory process.
click here to find a list of AC1O426C suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing AC1O426C as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for AC1O426C API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture AC1O426C as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain AC1O426C and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a AC1O426C NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of AC1O426C suppliers with NDC on PharmaCompass.
AC1O426C Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AC1O426C GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AC1O426C GMP manufacturer or AC1O426C GMP API supplier for your needs.
A AC1O426C CoA (Certificate of Analysis) is a formal document that attests to AC1O426C's compliance with AC1O426C specifications and serves as a tool for batch-level quality control.
AC1O426C CoA mostly includes findings from lab analyses of a specific batch. For each AC1O426C CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AC1O426C may be tested according to a variety of international standards, such as European Pharmacopoeia (AC1O426C EP), AC1O426C JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AC1O426C USP).
